Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade.

Source:http://linkedlifedata.com/resource/pubmed/id/10408857

Download in:

View as

General Info

PMID
10408857